Mrs. Iris Bincovich is an experienced healthcare manager, with a proven track record in developing global business strategies to open and penetrate new markets. With nearly 20 years of international marketing, biz dev and sales experience, she has led and managed hundreds of successful international transactions in the OTC, cosmetics and dermatology sector.

Iris was formerly the VP Global Marketing & Sales for the OTC botanical specialist, Kamedis, where she established their successful International marketing strategy including establishing digital marketing platform and global e-commerce site. She has also led the marketing/sales strategy and world-wide distribution network for a variety of dermatology, cosmetic and OTC companies (Promedico (Wellcome), Pollogen (Lumenis; NASDAQ: LMNS), Starlet Derma, Power Paper) and has worked with leading international cosmetic customers (Estee Lauder, L’Oreal, J&J, Channel, etc.).

Whilst serving as the Business Unit Manager for Tagra, she accompanied the biotechnology startup from early stage to commercialization and established their worldwide distribution network.

​​

Over 20 years of experience in global eCommerce and technology with a focus on Digital, Analytics and Data. Roni has scaled eCommerce startups from an early stage to 9 figures in revenue.

Extensive experience as CFO for public and private companies. Member of the Chartered Professional Accountants of Alberta. Received a Distinguished Service Award from the Chartered Professional Accountants of Alberta in 2005 and received an “FCA” designation as a Fellow Chartered accountant in 2013 for his contribution to his community and the profession.

Dr.Eyal Kalo earned his Ph.D from the Weizmann Institute of Science mastering in the field of cancer research. Eyal completed his studies in 2010 and joined the biotechnology industry where he gained expertisse in leading various R&D projects from concept to launch in the field of medical diagnostics, and natural medicine. Eyal worked as a scientific team leader at the molecular diagnostic division of Beckman Coulter and was responsible for the development of an FDA approved molecular-based diagnostic assay to detect HIV in patients. Prior to that, he served as a senior project manager at IBR Ltd. A company that is under IFF’s structure and develops, manufactures and markets innovative and proprietary natural active ingredients.

Certified Public Accountant with extensive experience as Director of Finance and Finance Manager of financial and retail public companies